Avantor, Inc.

NYSE:AVTR Stock Report

Market Cap: US$14.4b

Avantor Valuation

Is AVTR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AVTR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AVTR ($21.21) is trading below our estimate of fair value ($29.31)

Significantly Below Fair Value: AVTR is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AVTR?

Key metric: As AVTR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AVTR. This is calculated by dividing AVTR's market cap by their current earnings.
What is AVTR's PE Ratio?
PE Ratio46.6x
EarningsUS$309.60m
Market CapUS$14.44b

Price to Earnings Ratio vs Peers

How does AVTR's PE Ratio compare to its peers?

The above table shows the PE ratio for AVTR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average68x
RVTY Revvity
53x19.6%US$13.7b
TECH Bio-Techne
77.2x21.2%US$11.6b
QGEN Qiagen
106.8x34.4%US$9.9b
WAT Waters
35.1x8.6%US$21.9b
AVTR Avantor
46.6x36.2%US$14.4b

Price-To-Earnings vs Peers: AVTR is good value based on its Price-To-Earnings Ratio (46.6x) compared to the peer average (68x).

Price to Earnings Ratio vs Industry

How does AVTR's PE Ratio compare vs other companies in the US Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
REPC.F RepliCel Life Sciences
0.3xn/aUS$325.01k
No more companies available in this PE range
AVTR 46.6xIndustry Avg. 36.2xNo. of Companies4PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AVTR is expensive based on its Price-To-Earnings Ratio (46.6x) compared to the Global Life Sciences industry average (36.2x).

Price to Earnings Ratio vs Fair Ratio

What is AVTR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AVTR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio46.6x
Fair PE Ratio38.6x

Price-To-Earnings vs Fair Ratio: AVTR is expensive based on its Price-To-Earnings Ratio (46.6x) compared to the estimated Fair Price-To-Earnings Ratio (38.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AVTR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$21.21
US$27.20
+28.2%
8.4%US$33.00US$23.00n/a19
Dec ’25US$21.06
US$27.31
+29.7%
7.8%US$33.00US$24.00n/a19
Nov ’25US$22.31
US$27.31
+22.4%
7.8%US$33.00US$24.00n/a19
Oct ’25US$25.42
US$28.60
+12.5%
7.6%US$34.00US$24.00n/a19
Sep ’25US$25.84
US$28.42
+10.0%
6.6%US$31.00US$24.00n/a19
Aug ’25US$26.50
US$28.33
+6.9%
6.7%US$31.00US$24.00n/a18
Jul ’25US$20.77
US$27.63
+33.0%
6.6%US$30.00US$23.00n/a18
Jun ’25US$24.08
US$27.80
+15.4%
6.2%US$30.00US$23.00n/a18
May ’25US$24.42
US$27.75
+13.6%
6.0%US$30.00US$23.00n/a19
Apr ’25US$25.24
US$27.38
+8.5%
6.5%US$30.00US$23.00n/a19
Mar ’25US$25.00
US$27.20
+8.8%
7.0%US$30.00US$23.00n/a19
Feb ’25US$23.56
US$25.05
+6.3%
8.8%US$30.00US$22.00n/a19
Jan ’25US$22.83
US$24.30
+6.4%
10.7%US$30.00US$19.50n/a20
Dec ’24US$21.38
US$23.25
+8.7%
11.6%US$30.00US$19.50US$21.0619
Nov ’24US$17.41
US$23.25
+33.5%
11.6%US$30.00US$19.50US$22.3119
Oct ’24US$21.08
US$24.61
+16.8%
9.2%US$30.00US$21.00US$25.4218
Sep ’24US$21.70
US$24.61
+13.4%
9.0%US$30.00US$21.00US$25.8418
Aug ’24US$20.89
US$24.67
+18.1%
9.2%US$30.00US$21.00US$26.5018
Jul ’24US$20.54
US$25.78
+25.5%
8.5%US$30.00US$22.00US$20.7718
Jun ’24US$19.90
US$25.71
+29.2%
8.7%US$30.00US$22.00US$24.0817
May ’24US$20.23
US$25.71
+27.1%
8.7%US$30.00US$22.00US$24.4217
Apr ’24US$21.14
US$28.06
+32.7%
6.4%US$30.00US$24.00US$25.2416
Mar ’24US$24.56
US$28.06
+14.2%
6.2%US$30.00US$24.00US$25.0017
Feb ’24US$24.43
US$26.94
+10.3%
7.1%US$30.00US$24.00US$23.5617
Jan ’24US$21.09
US$26.94
+27.7%
9.4%US$33.00US$23.00US$22.8317
Dec ’23US$22.80
US$27.13
+19.0%
9.2%US$33.00US$23.00US$21.3816

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Avantor, Inc. is covered by 35 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research
Luke SergottBarclays